Solid forms comprising a nr2b nam antagonist
TW202626620APending Publication Date: 2026-07-01NEUROCRINE BIOSCIENCES INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114135373
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-09-16
- Filing Date
- 2025-09-15
- Publication Date
- 2026-07-01
Abstract
Solid forms comprising (4S,5S)-1-({6-[4-(difluoromethyl)-2-fluorophenoxy]pyridin-3-yl}methyl)-4-hydroxy-5-methylpyrrolidine-2-one (Compound (I)), compositions comprising the same, and methods of making and using the same, for example, in the prevention or treatment of a central nervous system disease.
Need to check novelty before this filing date? Find Prior Art